Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Azathioprine/Ciclosporin/Rituximab

Transient neutropenia, hypogammaglobulinaemia and lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ren J, et al. Case report: Persistent hypogammaglobulinemia in thymoma-associated myasthenia gravis: the impact of rituximab or Good's syndrome?. Frontiers in Neurology 14: no pagination, May 2023. Available from: URL: 10.3389/fneur.2023.1152992 Ren J, et al. Case report: Persistent hypogammaglobulinemia in thymoma-associated myasthenia gravis: the impact of rituximab or Good's syndrome?. Frontiers in Neurology 14: no pagination, May 2023. Available from: URL: 10.3389/fneur.2023.1152992
Metadaten
Titel
Azathioprine/Ciclosporin/Rituximab
Transient neutropenia, hypogammaglobulinaemia and lack of efficacy
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-53711-2

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Apalutamide

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Regorafenib

Case report

Blinatumomab